New Enterprise Associates related stories
All articles and analysis
- Mighty Ai bags $14 mln: Tech Portal
Mighty Ai (formerly known as Spare5) an artificial intelligence company, has secured $14 million in funding, according to tech news site Tech Portal http://thetechportal.com/2017/01/11/spare5-re-launched-mighty-ai/ Intel Capital led the round with participation from other investors that included Accenture Ventures, GV, Foundry Group, Madrona Venture Group and New Enterprise Associates.
- NEA leads Series E round for Cartiva
Alpharetta, Georgia-based Cartiva Inc, a developer of products that treat cartilage damage and osteoarthritis, has secured $8.5 million in Series E financing. New Enterprise Associates led the round with participation from other other investors that included Windham Venture Partners.
- RA Capital leads Series C round for Ivantis
Irvine, California-based Ivantis Inc, a developer of a device for glaucoma patients, has raised $25 million in Series C funding. RA Capital Management led the round with participation from other backers that included Mérieux Développement.
- Bitglass snags $45 mln Series C
Silicon Valley-based Bitglass, a data protection company, has secured $45 million in Series C funding. The investors included Future Fund, New Enterprise Associates, Norwest and SingTel Innov8.
- Fugue raises $41 mln
Fugue Inc said Jan. 5 that closed a roughly $41 million Series D financing round led by New Enterprise Associates. Prior investor Maryland Venture Fund and new investor Future Fund, the sovereign wealth fund of Australia, also participated. Fugue, of Frederick, Maryland, provides a software-defined system for orchestrating and enforcing cloud infrastructure at scale. Morrison & Foerster LLP served as legal counsel to Fugue.
- Intact Vascular racks up $46 mln Series B
Intact Vascular Inc, which develops medical devices for minimally invasive vascular procedures, has raised a total of $46 million in Series B funding. The investors were New Enterprise Associates, Quaker Partners and H.I.G. BioHealth Partners.



